Insider Selling: Aveanna Healthcare (NASDAQ:AVAH) CEO Sells 168,800 Shares of Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) CEO Jeff Shaner sold 168,800 shares of the firm’s stock in a transaction dated Wednesday, February 18th. The stock was sold at an average price of $7.38, for a total transaction of $1,245,744.00. Following the completion of the sale, the chief executive officer owned 2,824,117 shares of the company’s stock, valued at $20,841,983.46. This trade represents a 5.64% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Jeff Shaner also recently made the following trade(s):

• On Thursday, February 19th, Jeff Shaner sold 173,225 shares of Aveanna Healthcare stock. The stock was sold at an average price of $7.21, for a total value of $1,248,952.25.
• On Tuesday, February 17th, Jeff Shaner sold 119,884 shares of Aveanna Healthcare stock. The stock was sold at an average price of $7.65, for a total value of $917,112.60.
• On Friday, January 2nd, Jeff Shaner sold 29,357 shares of Aveanna Healthcare stock. The shares were sold at an average price of $7.85, for a total value of $230,452.45.
• On Wednesday, December 31st, Jeff Shaner sold 27,674 shares of Aveanna Healthcare stock. The shares were sold at an average price of $8.18, for a total value of $226,373.32.
• On Tuesday, December 30th, Jeff Shaner sold 27,929 shares of Aveanna Healthcare stock. The stock was sold at an average price of $8.36, for a total transaction of $233,486.44.

Aveanna Healthcare Stock Up 0.3%

Shares of Aveanna Healthcare stock traded up $0.02 during trading on Thursday, hitting $7.42. The company’s stock had a trading volume of 3,877,110 shares, compared to its average volume of 938,081. Aveanna Healthcare Holdings Inc. has a 52 week low of $3.67 and a 52 week high of $10.32. The company has a market capitalization of $1.55 billion, a PE ratio of 20.61 and a beta of 2.06. The company has a fifty day simple moving average of $8.48 and a two-hundred day simple moving average of $8.44. The company has a debt-to-equity ratio of 140.39, a quick ratio of 1.23 and a current ratio of 1.23.

Institutional Investors Weigh In On Aveanna Healthcare

Large investors have recently bought and sold shares of the business. AustralianSuper Pty Ltd purchased a new position in Aveanna Healthcare in the 3rd quarter worth about $15,743,000. Vanguard Group Inc. grew its stake in shares of Aveanna Healthcare by 38.0% in the fourth quarter. Vanguard Group Inc. now owns 5,577,010 shares of the company’s stock worth $45,564,000 after acquiring an additional 1,535,351 shares during the period. Millennium Management LLC raised its holdings in shares of Aveanna Healthcare by 1,007.1% during the fourth quarter. Millennium Management LLC now owns 1,114,717 shares of the company’s stock valued at $9,107,000 after purchasing an additional 1,014,030 shares during the last quarter. Nuveen LLC raised its holdings in shares of Aveanna Healthcare by 135.9% during the fourth quarter. Nuveen LLC now owns 1,571,308 shares of the company’s stock valued at $12,838,000 after purchasing an additional 905,316 shares during the last quarter. Finally, Hillsdale Investment Management Inc. bought a new position in Aveanna Healthcare during the third quarter valued at approximately $7,922,000. 87.96% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of research analysts recently weighed in on the company. Zacks Research lowered Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, February 3rd. Barclays increased their target price on Aveanna Healthcare from $9.00 to $11.00 and gave the stock an “overweight” rating in a research note on Friday, January 16th. BMO Capital Markets started coverage on Aveanna Healthcare in a research report on Thursday, November 13th. They issued an “outperform” rating and a $11.00 price target for the company. Jefferies Financial Group upped their price target on shares of Aveanna Healthcare from $11.00 to $12.50 and gave the stock a “buy” rating in a research note on Tuesday, October 28th. Finally, Truist Financial increased their price objective on shares of Aveanna Healthcare from $9.50 to $10.00 and gave the company a “hold” rating in a research report on Friday, November 7th. Five analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $11.06.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.